Correlation Between Revelation Biosciences and Wesana Health

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Revelation Biosciences and Wesana Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revelation Biosciences and Wesana Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revelation Biosciences and Wesana Health Holdings, you can compare the effects of market volatilities on Revelation Biosciences and Wesana Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revelation Biosciences with a short position of Wesana Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revelation Biosciences and Wesana Health.

Diversification Opportunities for Revelation Biosciences and Wesana Health

0.33
  Correlation Coefficient

Weak diversification

The 3 months correlation between Revelation and Wesana is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Revelation Biosciences and Wesana Health Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Wesana Health Holdings and Revelation Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revelation Biosciences are associated (or correlated) with Wesana Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Wesana Health Holdings has no effect on the direction of Revelation Biosciences i.e., Revelation Biosciences and Wesana Health go up and down completely randomly.

Pair Corralation between Revelation Biosciences and Wesana Health

Assuming the 90 days horizon Revelation Biosciences is expected to generate 32.04 times less return on investment than Wesana Health. But when comparing it to its historical volatility, Revelation Biosciences is 20.1 times less risky than Wesana Health. It trades about 0.14 of its potential returns per unit of risk. Wesana Health Holdings is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest  1.50  in Wesana Health Holdings on November 3, 2024 and sell it today you would earn a total of  2.25  from holding Wesana Health Holdings or generate 150.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy95.45%
ValuesDaily Returns

Revelation Biosciences  vs.  Wesana Health Holdings

 Performance 
       Timeline  
Revelation Biosciences 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Revelation Biosciences are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental drivers, Revelation Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.
Wesana Health Holdings 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Wesana Health Holdings are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite nearly abnormal basic indicators, Wesana Health reported solid returns over the last few months and may actually be approaching a breakup point.

Revelation Biosciences and Wesana Health Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Revelation Biosciences and Wesana Health

The main advantage of trading using opposite Revelation Biosciences and Wesana Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revelation Biosciences position performs unexpectedly, Wesana Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Wesana Health will offset losses from the drop in Wesana Health's long position.
The idea behind Revelation Biosciences and Wesana Health Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges